Skip to main content
Log in

Optimization of the preparation of153Sm-EDTMP using natural samarium targets for clinical use

  • Published:
Journal of Radioanalytical and Nuclear Chemistry Aims and scope Submit manuscript

Abstract

153Sm (specific activity 3.7 to 5.55 GBq/mg) was produced by irradiating natural Sm2O3 at a flux of 2.2·1013 n·cm−2·s−1. Ethylenediaminetetramethylenephosphonate (EDTMP) was synthesised according to a reported method. Complexation was carried out by varying experimental parameters such as mole ratios of metal to ligand, pH, time and temperature of reaction to obtain quantitative yields. The radiochemical purity of the complex was assessed by various analytical techniques including HPLC. In vitro ligand exchange studies were undertaken to ensure suitability of the product for therapy. Biodistribution studies were carried out in Wistar rats and adequate bone uptake, retention and rapid clearance from blood stream were observed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. M. A. Winston, Semin. Nucl. Med., 2 (1979) 114.

    Google Scholar 

  2. J. C. Harbert, Radionuclide therapy of bone pain, in: Nuclear Medicine Therapy, Thieme Medical Publishers, New York, 1987.

    Google Scholar 

  3. E. Kaplan, in: Therapy in Nuclear Medicine,R. Spencer (Ed.), Grune & Stratton, New York, 1978, p. 237.

    Google Scholar 

  4. A. Cheung, A. A. Driedger, Radiol., 134 (1980) 209.

    CAS  Google Scholar 

  5. V. J. Lewington, Eur. J. Nucl. Med., 20 (1990) 66.

    Google Scholar 

  6. J. Simon, W. F. Goeckeler, B. Edwards, L. Stringham, W. A. Volkert, D. E. Troutner, R. A. Holmes, S. Harry, J. Label. Comp. Radiopharm. 23 (1986) 1344.

    Google Scholar 

  7. W. F. Goeckeler, D. E. Troutner, W. A. Volkert, Nucl. Med. Biol., 14 (1986).

  8. A. R. Ketring, Nucl. Med. Biol., 14 (1987) 223.

    CAS  Google Scholar 

  9. W. A. Volkert, J. Simon, A. R. Ketring, R. A. Holmes, L. C. Lattimer, L. A. Corwin, Drugs of the Future, 4 (1989) 799.

    Google Scholar 

  10. J. C. Lattimer, W. F. Goeckeler, J. Nucl. Med., 31 (1990) 586.

    CAS  Google Scholar 

  11. P. Saraswathy, D. V. S. Narasimhan, P. S. Balasbramanian, D. K. Ranganatha, U. N. Nayak, R. B. Patel, P. Ramanathan, IJNM, 12 (1997) 191.

    Google Scholar 

  12. K. Moedritzer, R. R. Irani, J. Org. Chem., 31 (1966) 1603.

    CAS  Google Scholar 

  13. W. F. Goeckeler, D. E. Troutner, W. A. Volkert, B. Edwards, J. Simon, D. Wilson, Nucl. Med. Biol., 13 (1986) 479.

    CAS  Google Scholar 

  14. Training Notes, IAEA Training Course on Therapeutic Radiopharmaceuticals, Beijing, China, Oct. 1997.

  15. M. A. Majali, A. R. Mathkar, H. H. shimpi, M. R. A. pillai, under preparation.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Majali, M.A., Mathakar, A.R. & Shimpi, H.H. Optimization of the preparation of153Sm-EDTMP using natural samarium targets for clinical use. J Radioanal Nucl Chem 240, 845–849 (1999). https://doi.org/10.1007/BF02349861

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02349861

Keywords

Navigation